These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2154082)

  • 21. A new family with dexamethasone-suppressible hyperaldosteronism: aldosterone unresponsiveness to angiotensin II.
    Fallo F; Sonino N; Armanini D; Luzzi T; Pedini F; Pasini C; Mantero F
    Clin Endocrinol (Oxf); 1985 Jun; 22(6):777-85. PubMed ID: 2990765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension.
    Gordon RD; Gomez-Sanchez CE; Hamlet SM; Tunny TJ; Klemm SA
    J Hypertens Suppl; 1987 Dec; 5(5):S103-6. PubMed ID: 2832571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [11-beta-hydroxylase deficiency and glucocorticoid-sensitive hyperaldosteronism].
    Merino Arribas JM; Rámila de la Torre E; Sánchez Martín J; Avellanosa Arnaiz A; González de la Rosa JB
    An Esp Pediatr; 1996 Jun; 44(6):609-11. PubMed ID: 8849112
    [No Abstract]   [Full Text] [Related]  

  • 24. Aldosterone response to sodium restriction and ACTH stimulation in panhypopituitarism.
    Williams GH; Rose LI; Dluhy RG; Dingman JF; Lauler DP
    J Clin Endocrinol Metab; 1971 Jan; 32(1):27-35. PubMed ID: 4321496
    [No Abstract]   [Full Text] [Related]  

  • 25. [Idiopathic hyperaldosteronism and the related dexamethasone suppressive hyperaldosteronism].
    Yasuda K; Miura K
    Nihon Naika Gakkai Zasshi; 1992 Apr; 81(4):517-22. PubMed ID: 1320089
    [No Abstract]   [Full Text] [Related]  

  • 26. Glucocorticoid-suppressible hyperaldosteronism: from confusion to conclusion?
    Jamieson A; Connell JM; Fraser R
    J Mol Endocrinol; 1993 Feb; 10(1):3-5. PubMed ID: 8383977
    [No Abstract]   [Full Text] [Related]  

  • 27. Study on clinical and endocrine characteristics of dexamethasone-suppressible hyperaldosteronism compared with those in primary aldosteronism owing to aldosterone-producing adenoma.
    Yamakita N; Yasuda K; Noritake N; Mercado-Asis LB; Murase H; Mune T; Morita H; Miura K
    Acta Endocrinol (Copenh); 1989 Sep; 121(3):334-44. PubMed ID: 2552725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for an unidentified ACTH-induced steroid hormone causing hypertension.
    New MI; Peterson RE; Saenger P; Levine LS
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1283-93. PubMed ID: 187612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Suppression of adrenal function by dexamethasone in radionuclide differential diagnosis of hyperaldosteronism].
    Ametov AS; Kramer AA; Abashidze RI
    Med Radiol (Mosk); 1980 Apr; 25(4):58-63. PubMed ID: 7382761
    [No Abstract]   [Full Text] [Related]  

  • 30. Primary aldosteronism with unusual secretory pattern.
    Biglieri EG; Slaton PE; Kronfield SJ; Deck JB
    J Clin Endocrinol Metab; 1967 May; 27(5):715-21. PubMed ID: 4290762
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of naloxone on the pituitary-adrenal axis in patients with dexamethasone-suppressible hyperaldosteronism.
    Fallo F; Boscaro M; Sonino N; Mantero F
    Clin Endocrinol (Oxf); 1987 Feb; 26(2):163-8. PubMed ID: 2822294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dexamethasone-suppressible hypertension.
    Stewart PM
    Lancet; 2000 Aug; 356(9231):697-9. PubMed ID: 11085685
    [No Abstract]   [Full Text] [Related]  

  • 33. Genetic and pathophysiologic studies of a new kindred with glucocorticoid-suppressible hyperaldosteronism manifest in three generations.
    Ganguly A; Grim CE; Bergstein J; Brown RD; Weinberger MH
    J Clin Endocrinol Metab; 1981 Nov; 53(5):1040-6. PubMed ID: 7026592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central serotonergic stimulation of aldosterone secretion.
    Shenker Y; Gross MD; Grekin RJ
    J Clin Invest; 1985 Oct; 76(4):1485-90. PubMed ID: 2997280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulation and suppression of aldosterone in plasma of normal man and in primary aldosteronism.
    Horton R
    J Clin Invest; 1969 Jul; 48(7):1230-6. PubMed ID: 4307457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Idiopathic hyperaldosteronism in a dog.
    Breitschwerdt EB; Meuten DJ; Greenfield CL; Anson LW; Cook CS; Fulghum RE
    J Am Vet Med Assoc; 1985 Oct; 187(8):841-5. PubMed ID: 2997095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renin, aldosterone and glucagon in the natriuresis of fasting.
    Spark RF; Arky RA; Boulter PR; Saudek CD; O'Brian JT
    N Engl J Med; 1975 Jun; 292(25):1335-40. PubMed ID: 165411
    [No Abstract]   [Full Text] [Related]  

  • 38. A new variant of 17 alpha-hydroxylase deficiency with hyperaldosteronism in two Japanese sisters.
    Monno S; Takasu N
    Endocrinol Jpn; 1989 Apr; 36(2):315-23. PubMed ID: 2550210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dexamethasone-suppressible hyperaldosteronism: pathophysiology, clinical aspects, and new insights into the pathogenesis.
    Fallo F; Sonino N; Boscaro M; Armanini D; Mantero F; Dörr HG; Knorr D; Kuhnle U
    Klin Wochenschr; 1987 May; 65(10):437-44. PubMed ID: 3037179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Episodic secretion of aldosterone in primary aldosteronism: relationship to cortisol.
    Vetter H; Berger M; Armbruster H; Siegenthaler W; Werning C; Vetter W
    Clin Endocrinol (Oxf); 1974 Jan; 3(1):41-8. PubMed ID: 4366076
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.